Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
173896 ARTíCULOS , VIENDO DEL 173296 AL 173310
[Regulation of cholesterol metabolism is neuroprotective in Huntington's disease].
Caboche J, Kacher R, Betuing S.
Med Sci (Paris). 2020 Jan;36(1):12-15. doi: 10.1051/medsci/2019253. Epub 2020 Feb 4. French. No abstract available.
0
0
0
Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.
Fernández-Nogales M, Lucas JJ.
Front Cell Neurosci. 2020 Jan 17;13:574. doi: 10.3389/fncel.2019.00574. eCollection 2019. Review.
0
0
0
Ghavami A, Olsen M, Kwan M, Beltran J, Shea J, Ramboz S, Duan W, Lavery D, Howland D, Park LC.
J Huntingtons Dis. 2020 Jan 28. doi: 10.3233/JHD-190389. [Epub ahead of print]
0
0
0
Prion-like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy.
Srinageshwar B, Petersen RB, Dunbar GL, Rossignol J.
Stem Cells Transl Med. 2020 Jan 30. doi: 10.1002/sctm.19-0248. [Epub ahead of print] Review.
0
0
0
He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH, Huang JJ.
Adv Sci (Weinh). 2019 Dec 9;7(2):1901165. doi: 10.1002/advs.201901165. eCollection 2020 Jan.
0
0
0
Management of dysphagia in Huntington's disease: a descriptive review.
Pizzorni N, Pirola F, Ciammola A, Schindler A.
Neurol Sci. 2020 Jan 27. doi: 10.1007/s10072-020-04265-0. [Epub ahead of print] Review.
0
0
0
Polosecki P, Castro E, Rish I, Pustina D, Warner JH, Wood A, Sampaio C, Cecchi GA.
Sci Rep. 2020 Jan 27;10(1):1252. doi: 10.1038/s41598-020-58074-8.
0
0
0
McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators..
J Huntingtons Dis. 2020 Jan 24. doi: 10.3233/JHD-190391. [Epub ahead of print]
0
0
0
Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers.
Cybulska K, Perk L, Booij J, Laverman P, Rijpkema M.
Molecules. 2020 Jan 23;25(3). pii: E482. doi: 10.3390/molecules25030482. Review.
0
0
0
Characterizing White Matter in Huntington's Disease.
Gregory S, Johnson E, Byrne LM, Rodrigues FB, Henderson A, Moss J, Thomas D, Zhang H, De Vita E, Tabrizi SJ, Rees G, Scahill RI, Wild EJ.
Mov Disord Clin Pract. 2019 Nov 28;7(1):52-60. doi: 10.1002/mdc3.12866. eCollection 2020 Jan.
0
0
0
Fazio P, Fitzer-Attas CJ, Mrzljak L, Bronzova J, Nag S, Warner JH, Landwehrmeyer B, Al-Tawil N, Halldin C, Forsberg A, Ware J, Dilda V, Wood A, Sampaio C, Varrone A; PEARL-HD and LONGPDE10 study colla
Mov Disord. 2020 Apr;35(4):606-615. doi: 10.1002/mds.27963. Epub 2020 Jan 22.
0
0
0
Preliminary data on prednisone effectiveness in children with Sydenham chorea.
Favaretto E, Gortani G, Simonini G, Pastore S, Di Mascio A, Cimaz R, Taddio A.
Eur J Pediatr. 2020 Jan 21. doi: 10.1007/s00431-020-03574-y. [Epub ahead of print]
0
0
0
Vernizzi L, Paiardi C, Licata G, Vitali T, Santarelli S, Raneli M, Manelli V, Rizzetto M, Gioria M, Pasini ME, Grifoni D, Vanoni MA, Gellera C, Taroni F, Bellosta P.
Cells. 2020 Jan 13;9(1). pii: E196. doi: 10.3390/cells9010196.
0
0
0
Therapeutic Advances for Huntington's Disease.
Kumar A, Kumar V, Singh K, Kumar S, Kim YS, Lee YM, Kim JJ.
Brain Sci. 2020 Jan 12;10(1). pii: E43. doi: 10.3390/brainsci10010043. Review.
0
0
0
The Renin-Angiotensin System in Huntington's disease: Villain or hero?
Machado TCG, Guatimosim C, Kangussu LM.
Protein Pept Lett. 2020 Jan 10. doi: 10.2174/0929866527666200110154523. [Epub ahead of print]
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
